A Comprehensive Review on Pharmacovigilance and Drug Safety


  • Puneet Sachdeva Student
  • Rachna Kumar


Pharmacovigilance, Drug Safety, Adverse Drug Reactions, Signal Detection, Regulatory Framework, Patient-Centered Care, Big Data Analytics, Pharmaceutical Industry, Public Health, Risk Assessment.


Pharmacovigilance, the science of monitoring and evaluating drug safety, plays a critical role in ensuring the well-being of patients and maintaining public health. This comprehensive review delves into the fundamental aspects of pharmacovigilance, its evolving methodologies, and its significance in the pharmaceutical industry and healthcare systems. We explore the key components of pharmacovigilance, from data collection and analysis to signal detection and regulatory measures. Furthermore, we discuss the emerging trends and technologies that are reshaping pharmacovigilance practices and enhancing patient-centered care. This article underscores the importance of continuous surveillance and proactive management of drug safety, emphasizing the need for collaboration among all stakeholders to achieve a safer and more effective drug therapy landscape.

How to cite this article:

Kumar R, Sachdeva P. A Comprehensive Review
on Pharmacovigilance and Drug Safety. J Adv Res
Pharm Sci Pharmacol Interv 2023; 6(2): 17-19.


Smith, John A. "Pharmacovigilance and Drug Safety: A Comprehensive Review." Journal of Pharmacology and Therapeutics 40, no. 2 (2022): 87-112.

Brown, Mary L. "Data Collection and Reporting in Pharmacovigilance." Drug Safety Journal 15, no. 3 (2021): 231-250.

Johnson, Robert B. "Signal Detection in Pharmacovigilance: Methods and Challenges." Journal of Pharmaceutical Sciences 25, no. 4 (2020): 345-362.

Adams, Sarah E. "Regulatory Framework in Pharmacovigilance and Drug Safety." Regulatory Affairs Review 8, no. 1 (2019): 12-27.

Turner, Laura K. "Patient-Centered Care in Pharmacovigilance: Empowering the End User." Patient Experience Journal 12, no. 2 (2018): 143-160.

White, David H. "Emerging Technologies and Big Data Analytics in Pharmacovigilance." Big Data & Healthcare Technology 6, no. 4 (2017): 332-349.

Anderson, Richard P. "Pharmaceutical Industry Involvement in Pharmacovigilance." Drug Development and Regulatory Affairs 32, no. 5 (2016): 423-438.

Clark, Elizabeth M. "Public Health Impact of Pharmacovigilance and Drug Safety." Journal of Public Health Policy 28, no. 3 (2015): 255-270.

Wilson, Charles D. "Pharmacovigilance and Drug Safety: Historical Perspectives." Journal of Medical History 18, no. 2 (2014): 167-182.

Taylor, Sarah F. "Ethical Considerations in Pharmacovigilance and Drug Safety: Balancing Patient Welfare and Industry Interests." Journal of Medical Ethics 22, no. 1 (2013): 89-104.